Researchers treated U937 macrophage cells with 250 micromolar dimethyl itaconate, or DMI, for 48 hours. They then isolated exosomes from the treated cultures, characterized the vesicles and applied them to MCF-7 cells. Western blotting was used to measure proteins associated with epithelial–mesenchymal transition, including E-cadherin, N-cadherin, ZEB1/2, Slug, and Vimentin. Exposure to the DMI-derived exosomes, designated DMI-EXO, significantly increased N-cadherin, ZEB1/2, Slug, and Vimentin while reducing E-cadherin. Together, these protein changes were consistent with a shift in the cancer cells toward a more mesenchymal state.

The investigators also examined microRNAs associated with EMT regulation. Quantitative real-time PCR showed that DMI-EXO significantly reduced miR200C-5p and miR30C-5p, two of the EMT-suppressive microRNAs assessed in the study. No significant change was detected in miR-137 expression. The results connect altered microRNA abundance with the protein changes associated with EMT, although the experiments do not establish that either microRNA was the direct mechanism responsible for migration or invasion. The study also evaluated miR-638, but the supplied results do not report a specific change in that microRNA.

Functional assays showed that the DMI-EXO treatment affected the movement of MCF-7 cells. In the scratch wound-healing assay, treated cells closed the artificial gap faster than comparison cells. In a Transwell invasion assay, the DMI-EXO group developed a larger invaded area. These measurements support enhanced migration and invasion, respectively. By contrast, Annexin V/propidium iodide staining showed no significant alteration in apoptosis after DMI-EXO exposure. The findings therefore point to changes in motility and invasion rather than a detectable change in cancer-cell death as the principal response under the experimental conditions.

This work provides evidence that macrophage-derived extracellular vesicles can transmit a tumor-associated influence between immune cells and breast cancer cells. Itaconic acid is an immunometabolite involved in macrophage polarization within the tumor microenvironment, but its effects on cancer progression have remained debated. The present results suggest one possible route: DMI treatment alters what macrophages release in exosomes, and those vesicles then promote EMT-associated protein and microRNA patterns together with greater migration and invasion in recipient MCF-7 cells. The findings are nevertheless limited to an in vitro cell-culture model, one macrophage cell line, one breast cancer cell line, and specified treatment conditions. They do not show that dimethyl itaconate produces the same effects in intact animals or people, and they do not demonstrate improved outcomes for patients with breast cancer.

Subject of Research: Effects of dimethyl-itaconate-treated macrophage exosomes on EMT, migration, invasion, and apoptosis in MCF-7 breast cancer cells

Article Title: Exosomes derived from itaconate-treated macrophages promote epithelial–mesenchymal transition, migration, and invasion in MCF-7 breast cancer cells

Article References: Siahi, F. H., Yektaseresht, A., & Tabandeh, M. R. (2026). Exosomes derived from itaconate-treated macrophages promote epithelial–mesenchymal transition, migration, and invasion in MCF-7 breast cancer cells. Medical Oncology, 43(11), Article 348. https://doi.org/10.1007/s12032-026-03468-3

Image Credits: AI Generated

DOI: 10.1007/s12032-026-03468-3

Keywords: breast cancer cells, macrophage exosomes, dimethyl itaconate, epithelial–mesenchymal transition, cell migration, cell invasion, microRNAs, tumor microenvironment, in vitro research, Exosomes, derived, itaconate-treated

The experiments used a 5 MHz AT-cut quartz crystal with a 13 mm active gold electrode in a QCM200 measurement system. The researchers loaded the central sensing surface with 400, 600, 800 microlitres or 1 millilitre of complete DMEM or complete RPMI-1640. Both media were prepared as sterile 1X solutions and supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Each condition was tested in three independent runs, with frequency and resistance recorded continuously for 120 minutes at intervals of 1.02 seconds. Measurements were conducted at approximately 25 degrees Celsius in an open chamber, and the crystal was allowed to settle for about one minute after loading.

The sensitivity comes from the fact that a quartz resonator measures more than added mass. Its oscillation interacts with the surrounding liquid, and the resulting electrical signals reflect both interfacial loading and energy dissipation. Classical QCM analysis treats the liquid primarily as a semi-infinite Newtonian medium into which the crystal launches shear waves. That simplified picture can omit longitudinal motion at the crystal surface and the compressional waves it creates. In a finite droplet, those waves travel through the liquid, reflect from the upper liquid-air boundary and return to the sensor, creating an acoustic cavity whose interference condition changes the effective load applied to the resonator.

The study describes this cavity with a Fabry–Perot-type model. Compressional-wave impedance depends on the liquid’s P-wave modulus, sound speed, density and wavenumber, together with the thickness of the liquid layer and the acoustic reflectivity of its boundaries. A phase factor determines how the returning wave changes the load, while the time for the liquid interface to shift by half a wavelength helps characterize the evolution of the impedance. The frequency and resistance channels respond through different physical pathways: frequency is tied more closely to the effective mass-loading response, whereas resistance reflects dissipation. Their oscillations can therefore differ in both phase and amplitude even when they are driven by the same changing acoustic condition.

Four temporal parameters were extracted from the time-resolved traces. The first was the characteristic period of the compressional-wave-induced modulation, which describes how rapidly the QCM response changes rather than how long a megahertz longitudinal wave takes to cross the liquid. The second and third were the peak-to-peak amplitudes of the frequency and resistance oscillations, measuring the total excursion of the apparent mass-loading and dissipative signals. The fourth quantified the time offset by which the resistance oscillation led the frequency oscillation. This phase difference provided evidence that the two electrical observables were responding differently as the acoustic interference condition evolved.

DMEM showed a clear transition with increasing volume. At 400 microlitres, the frequency and resistance traces remained comparatively smooth and slowly oscillating, alongside a continuous decrease in frequency. At 600 microlitres, the oscillations became more stable and exhibited little drift. At 800 microlitres and 1 millilitre, the records developed more irregular, higher-frequency fluctuations. Across the media, the characteristic modulation period shortened from approximately 40 minutes at the lower volumes to approximately 5 minutes as the volume increased. The period was more reproducible than the modulation amplitudes, which showed greater variability across repeated measurements.

RPMI-1640 followed the same broad volume-dependent pattern but developed high-frequency fluctuations at a lower loading: they were already noticeable at 600 microlitres. At 1 millilitre, its traces became strongly irregular, with substantial fluctuations throughout the 120-minute recording. Water provided a useful comparison because it displayed the most pronounced compressional-wave behaviour. Its frequency and resistance modulation amplitudes were consistently the largest, while its characteristic periods were the shortest. High-frequency fluctuations were visible in water at 800 microlitres. These comparisons show that neither liquid volume nor medium composition can be considered in isolation: the acoustic response emerged from their combined influence on wave reflection, attenuation and cavity geometry.

Increasing the volume does not necessarily enlarge the relevant acoustic path in direct proportion to the added liquid. Additional fluid can spread laterally across the sensor as well as deepen the layer above the active region. The experimental volume series establishes the overall trend, but the authors did not independently measure cavity thickness or acoustic path length for every loading condition. Their model explains how a changing phase factor can alter compressional-wave impedance, whereas the experiments associate that effect with droplet volume. A fully quantitative mapping between dispensed volume and cavity thickness would require separate geometric and acoustic characterization, which the study did not perform.

Several other limitations constrain how the results should be interpreted. The repeated runs were used to describe variability rather than to establish statistical significance because no formal hypothesis test was conducted. Ambient pressure and relative humidity were not independently monitored, although the large droplets produced no significant visible evaporation during the measurements. The experiments were performed outside a biological safety cabinet in an open measurement chamber, and the results concerned complete media at room temperature on one type of 5 MHz sensor. The work therefore establishes a baseline under the stated conditions rather than a universal correction rule for every QCM geometry, medium formulation or biological assay. The reported standard deviation and mean values also should not be mistaken for evidence of a formal group difference.

For researchers using QCMs to study breast cancer cell adhesion, growth or other cellular dynamics, the practical implication is that medium-only measurements should be collected under the same loading and timing conditions as cell-containing experiments. A frequency shift or resistance change should not automatically be assigned to cells when the liquid itself supports cavity-mediated compressional-wave modulation. The study’s next stage is to incorporate the identified medium response as a baseline correction in experiments involving breast cancer cells. That step could improve the interpretation of mass-loading and viscoelastic signals, although the present research did not test cells, demonstrate improved diagnostic performance or establish a clinical benefit.

Subject of Research: Compressional acoustic-wave effects in QCM measurements of breast cancer cell culture media

Article Title: Analysis of compressional acoustic wave responses in cell culture media for reliable QCM-based breast cancer cell monitoring

Article References: Kannan, H., Babu, R. P., Ghosh, T., Mohapatra, A., Dutta, M., & Ganesan, A. (2026). Analysis of compressional acoustic wave responses in cell culture media for reliable QCM-based breast cancer cell monitoring. Frontiers in Sensors, 7, Article 1949532. https://doi.org/10.3389/fsens.2026.1949532

Image Credits: AI Generated

DOI: 10.3389/fsens.2026.1949532

Keywords: quartz crystal microbalance, breast cancer cells, cell culture media, compressional acoustic waves, biosensors, DMEM, RPMI-1640, acoustic cavity, mass loading, liquid-phase sensing, Analysis, compressional

The research team began with a straightforward question: if edible mushrooms are increasingly recognized as reservoirs of bioactive anticancer compounds, what might P. eous hold? The species is known to be rich in phenolic and terpenoid constituents, two broad chemical families with well-documented biological activity, yet its potential against cancer cells had never been systematically evaluated. To answer the question, the investigators prepared a methanolic extract of the mushroom fruiting bodies and subjected it to gas chromatography-mass spectrometry, or GC-MS, a technique that vaporizes chemical compounds and separates them by mass, allowing researchers to identify individual molecules within a complex mixture. The spectral data, matched against reference libraries maintained by the National Institute of Standards and Technology, revealed a phytochemical profile that immediately caught the authors’ attention.

Among the compounds identified were carvacrol, quinic acid, and a derivative of cinnamic acid. Each of these molecules carries an established scientific pedigree. Carvacrol, the monoterpene phenol that gives oregano and thyme their characteristic aroma, has been repeatedly studied for antimicrobial, antioxidant, and pro-apoptotic effects in cancer models. Quinic acid, a cyclitol found in coffee and many plants, is a building block of chlorogenic acid and has been linked to anti-inflammatory and chemopreventive activity. Cinnamic acid derivatives, meanwhile, appear throughout the plant and fungal kingdoms and have been investigated for their ability to interfere with tumor cell proliferation. The presence of all three in a single mushroom extract suggested that P. eous might be more than an ordinary culinary fungus, prompting the team to move from chemical identification to biological testing.

The first biological assay targeted oxidative chemistry. The researchers used the DPPH assay, a widely employed colorimetric test in which the purple-colored free radical 2,2-diphenyl-1-picrylhydrazyl loses its absorbance when neutralized by antioxidants. The results were dramatic: at a concentration of 700 micrograms per milliliter, the P. eous extract scavenged 97.39 percent of the DPPH radicals, an efficiency approaching that of synthetic reference antioxidants. Complementing this, the team measured total phenolic content using the Folin-Ciocalteu assay, which quantifies phenolic compounds by their ability to reduce a phosphotungstic-phosphomolybdic acid reagent, expressed here in gallic acid equivalents. The extract yielded a total phenolic content of 2.80 plus or minus 0.04 milligrams of gallic acid equivalent per gram of dry weight. The strong radical-scavenging performance is consistent with the idea that phenolic compounds donate hydrogen atoms or electrons to stabilize reactive radicals, a mechanism thought to contribute to chemoprevention by protecting cellular DNA from oxidative damage.

The centerpiece of the study, however, was the cytotoxicity testing against MCF-7 cells, one of the most extensively characterized human breast cancer cell lines in existence. Originally isolated in 1970 from a patient with invasive breast carcinoma, MCF-7 cells are estrogen-receptor positive and serve as a standard in vitro model for hormone-responsive breast cancer, the most common malignancy in women worldwide. The researchers cultured the cells in Dulbecco’s Modified Eagle Medium supplemented with fetal bovine serum and exposed them to escalating concentrations of the mushroom extract. Cell viability was quantified with the MTT assay, a metabolic test in which living cells reduce a yellow tetrazolium salt into purple formazan crystals; the amount of formazan produced serves as a proxy for the number of metabolically active, surviving cells. Doxorubicin, a mainstay anthracycline chemotherapy drug, served as the positive control against which the extract’s performance could be benchmarked.

The outcome was unambiguous. The extract killed MCF-7 cells in a dose-dependent fashion, achieving a half-maximal inhibitory concentration, or IC50, of 82.69 micrograms per milliliter at the 24-hour time point. In pharmacological terms, the IC50 represents the concentration of a compound required to reduce cell viability by half, and values in the low tens to hundreds of micrograms per milliliter are considered meaningful starting points for natural product screening. Microscopic examination of the treated cultures revealed morphological changes characteristic of apoptosis, the programmed cell death pathway that cancer cells often evade. Cells exposed to higher concentrations of the extract displayed the shrinkage, rounding, and detachment that pathologists associate with cells undergoing self-destruction rather than simple toxic necrosis. Statistical analysis by analysis of variance followed by Tukey’s post-hoc test confirmed that the differences between treated and untreated groups were highly significant, with a p-value below 0.0001, meaning the probability that the observed effect arose by chance is vanishingly small.

The authors attribute the extract’s dual antioxidant and cytotoxic activity to its phenolic and terpenoid content, and the mechanistic logic is plausible. Phenolic compounds can act as pro-oxidants at high intracellular concentrations, tipping the redox balance of cancer cells, which already live under elevated oxidative stress, past the point of no return and triggering apoptotic signaling. Terpenoids such as carvacrol have been shown in other systems to disrupt mitochondrial membrane potential, activate caspase enzymes, and interfere with cell cycle progression. Quinic acid derivatives may contribute through modulation of inflammatory pathways that sustain tumor growth. It is important to stress, however, that the present study identifies associations rather than definitive mechanisms. The extract is a mixture of many compounds, and the specific molecule or combination of molecules responsible for killing MCF-7 cells has not yet been isolated or proven.

That caveat leads directly to the study’s stated limitations and next steps. The authors are explicit that further in vivo studies and compound purification are needed to confirm the observed effects and to clarify the underlying mechanisms. In vitro cell culture, while indispensable for screening, cannot capture the pharmacokinetics of a real organism: how a compound is absorbed, distributed, metabolized, and excreted, whether it reaches tumor tissue at active concentrations, and whether it harms healthy cells along the way. A crude methanolic extract that kills cancer cells in a dish may contain molecules that are too toxic, too unstable, or too poorly absorbed to ever become medicine. The purification pipeline, typically involving high-performance liquid chromatography fractionation followed by bioassay-guided testing, will be essential to isolate the active principles and determine whether a single compound or a synergistic ensemble is responsible.

Nevertheless, the study lands at a moment of surging interest in fungi as pharmaceutical factories. Mushrooms occupy a unique ecological niche as decomposers, and their evolutionary pressure to produce defensive secondary metabolites has equipped them with an extraordinary chemical arsenal. Established drugs derived from fungi include the statins, the immunosuppressant cyclosporine, and antibiotics such as penicillin, while mushroom-derived polysaccharides like lentinan from shiitake have been approved as adjuvant cancer therapies in some countries. Edible oyster mushrooms of the Pleurotus genus are particularly attractive candidates because they are cheap to cultivate on agricultural waste, fast-growing, and already consumed safely by millions of people, which simplifies the safety profile questions that plague many natural product candidates.

For now, the message for the public is one of measured enthusiasm rather than self-medication. Eating oyster mushrooms will not deliver the concentrated, chemically characterized extract tested in this study, and no clinical evidence yet supports any therapeutic use of P. eous in cancer patients. What the research does provide is a rigorous, statistically robust foundation for the next phase of investigation: isolating the active molecules, testing them against normal cells to establish selectivity, validating the findings in animal models, and ultimately, if the results hold, advancing toward clinical evaluation. Breast cancer remains one of the most prevalent malignancies worldwide, and the search for new agents, particularly those derived from accessible natural sources, remains urgent. A mushroom that most people walk past in the grocery aisle may, with enough scientific scrutiny, turn out to harbor chemistry worth far more than its weight in the produce bin. The journey from laboratory dish to pharmacy shelf is long and uncertain, but every credible candidate discovered along the way improves the odds.

Subject of Research: Anticancer and antioxidant potential of Pleurotus eous mushroom extract against human breast cancer MCF-7 cells in vitro

Article Title: Evaluation of the anticancer potential of Pleurotus eous against human breast cancer MCF-7 cell line

Article References: Al Qutaibi, M., & Kagne, S. R. (2026). Evaluation of the anticancer potential of Pleurotus eous against human breast cancer MCF-7 cell line. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05582-1

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05582-1

Keywords: Pleurotus eous, oyster mushroom, breast cancer, MCF-7, anticancer, antioxidant, GC-MS, MTT assay, carvacrol, phenolic compounds, apoptosis, natural products